Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.8700
-0.0500 (-5.43%)
Oct 10, 2025, 12:16 PM EDT - Market open

Immunic Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Net Income
-101.84-100.51-93.61-120.41-92.95-44.02
Upgrade
Depreciation & Amortization
0.160.130.110.080.090.04
Upgrade
Stock-Based Compensation
7.848.537.17.935.952.75
Upgrade
Other Adjustments
-6.520.5237.7312.96-2.53
Upgrade
Changes in Accounts Payable
-0.733.150.820.80.181
Upgrade
Changes in Accrued Expenses
3.01-4.8610.281.363.180.67
Upgrade
Changes in Other Operating Activities
1.242.283.957.37-12.63-4.03
Upgrade
Operating Cash Flow
-90.14-84.77-70.83-65.14-83.23-46.12
Upgrade
Capital Expenditures
-0.14-0.26-0.33-0.11-0.07-0.15
Upgrade
Proceeds from Sale of Investments
--9.8-9.63--
Upgrade
Investing Cash Flow
-0.14-0.269.46-9.74-0.07-0.15
Upgrade
Issuance of Common Stock
-0.271.0395.7642.84144.43
Upgrade
Net Common Stock Issued (Repurchased)
-0.271.0395.7642.84144.43
Upgrade
Other Financing Activities
-74.27----
Upgrade
Financing Cash Flow
-74.541.0395.7642.84144.43
Upgrade
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.3-0.520.26-0.99-0.13-0.08
Upgrade
Net Cash Flow
-24.39-11.01-60.0719.88-40.5998.08
Upgrade
Beginning Cash & Cash Equivalents
79.746.67106.7586.86127.4529.37
Upgrade
Ending Cash & Cash Equivalents
55.3135.6746.67106.7586.86127.45
Upgrade
Free Cash Flow
-90.28-85.03-71.16-65.26-83.3-46.27
Upgrade
Free Cash Flow Per Share
-0.83-0.85-1.61-2.05-3.52-2.95
Upgrade
Levered Free Cash Flow
-98.29-100.07-78.79-110.91-102.21-46.49
Upgrade
Unlevered Free Cash Flow
-101.72-97.62-84.4-109.99-100.93-51.44
Upgrade
Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q